The third and final module of the IPPOSI Pilot Patient Education Programme (running from January 22nd – March 12th 2018) will focus on Health Technology Assessment (HTA).
The objective is to provide students with a true picture of how such assessments are conducted in Ireland. As with the previous two modules (covering Clinical Trials and Regulatory Affairs), this blended learning module aims to equip students with the necessary knowledge, skills and understanding to become the embodiment of public & patient involvement (PPI) in research in Ireland.
Module 3 is being delivered through a partnership between IPPOSI and a number of education partners, including the Department of Pharmacology & Therapeutics, Trinity College Dublin, in association with the National Centre for Pharmaco-economics (NCPE), and the Health Information and Quality Authority (HIQA). The students will be taught by Irish scientists and experts, all of whom are actively involved in health technology assessment in Ireland.
Students will be able to rely on the support of EUPATI Fellow Rachel Lynch, who kindly agreed to provide help and advice for this complex module. IPPOSI is indebted to Rachel, and to the other Irish EUPATI fellows for their assistance in delivering the Pilot Programme.
The pilot education programme was conceived through IPPOSI’s experience within EUPATI, in partnership with the following Irish education partners:
- University College Dublin Clinical Research Centre
- The Health Products Regulatory Authority (HPRA)
- The Department of Pharmacology & Therapeutics, Trinity College Dublin, in association with the National Centre for Pharmacoeconomics (NCPE) and the Health Information & Quality Authority (HIQA)
You can find more information about the programme on our website here.
